Photo via Fox News

Women turn to testosterone for low sex drive as doctors confront treatment ‘experimentation’

Read the original at Fox News ↗
Cite

Quill, K. (2026, September 19). Women turn to testosterone for low sex drive as doctors confront treatment ‘experimentation’. Fox News. https://www.foxnews.com/health/women-turn-testosterone-low-sex-drive-doctors-confront-treatment-experimentation

Dated when The Aporia collected the article, usually within hours of publication. Check the original for its exact date and byline.

Fox News · collected 2026-09-19 · by Khloe Quill

Quick Summary

Doctors and patients are facing challenges due to the lack of FDA-approved testosterone products for women in the U.S., leading many women to seek testosterone therapy for menopause symptoms like low sexual desire. At a recent FDA workshop, concerns were raised about insurance denials, off-label prescribing, and dosing difficulties when using male formulations. Dr. Kudzai Dombo, an obstetrician-gynecologist from Los Angeles, describes how patients often ask about testosterone after starting estrogen and progesterone treatments, but she faces hurdles like administrative burdens and high costs due to the lack of standardized female-specific options.
Written by AI on 2026-09-19, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

FDA convened a public workshop to examine the rising off-label use of testosterone among menopausal women, amid concerns over its long-term safety. Clinicians are prescribing testosterone products designed for men at smaller doses due to a lack of FDA-approved formulations for women in the U.S. Studies show that while adult males have about 15 times more total testosterone than females, this hormone is still abundant in premenopausal women, produced at roughly three times the rate of estrogen. As women age and their testosterone levels decline, they may experience bone density loss, muscle mass reduction, cognitive decline, mood changes, sexual dysfunction, and decreased energy. Dr. Christina Chang from FDA's Center for Drug Evaluation and Research warned that there are no approved uses for testosterone therapy specifically for menopausal women in the U.S., highlighting the need for more research on its safety and efficacy.

Written for “Testosterone Use For Menopause Symptoms” on 2026-11-02, grounded in this article and the 1 other(s) covering the same event.

Story

📰 Testosterone Use For Menopause Symptoms
Health · 2 article(s) covering the same event. See how they differ ↓

Compared with similar articles

This article reads unscored and hedges 13% of its claims. Each row says how that neighbour differs.
CBS News
Hedges 2 of 3 claims Outlet record 66/100
“The articles describe different events: one is a discussion on a health program about vaginal hormones, while the other reports on an FDA public workshop regarding testosterone therapy for menopausal women.”
ABC News (US)
Hedges 2 of 19 claims Outlet record 70/100
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
23
sentences that state something as happening or true
Uncertain
13%
3 of 23 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
69/100
Fox News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
2
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-09-19 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

Fox News · 6284 article(s) · 11 correction(s) detected
Running correction rate · 11 correction(s)

Who wrote this

Khloe Quill
26 article(s) here · 1 carrying a prediction
🔮 People who lose weight through crash dieting or appetite-suppressing medications may shed muscle along with fat, experts warn.
🔮 " Some people may maintain friendships while leaving open the possibility of a future romantic relationship, Trombetti said.
🔮 "From a clinical perspective, is helpful to review medications with the autistic patient's physicians and, if possible, try to avoid medications that may cause a Parkinson's appearance."
🔮 While immediate effects may appear as hoarseness, coughing, or reduced athletic endurance, the larger impact poses risks to long-term vital organ function.
🔮 Brain games, crosswords and math puzzles are often promoted as ways to sharpen memory, but neurologists warn that generic exercises may not address the specific cause of mental fog.
🔮 While immediate effects may appear as hoarseness, coughing, or reduced athletic endurance, the larger impact poses risks to long-term vital organ function.
🔮 "Daytime napping may compensate for poor nighttime sleep, but it may also reduce the drive to sleep at night, potentially contributing to nighttime sleep disturbances, another important potential risk factor for dementia."
🔮 However, taking prescription ADHD medication may offer a protective benefit, lowering overall risk of death, the review found.
🔮 He believes the early results will translate into "clinical improvements with longer-term treatment." The latest skin-aging findings have been presented at a scientific conference, but have not yet been published as a full peer-reviewed study.
🔮 As Americans live longer, experts say everyday habits may be taking a toll on eye health earlier than expected.
Also by Khloe Quill
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 26 articles by Khloe Quill →

Topics

Alloy Health FDA Menopause Society U.S. the Food and Drug Administration

Subjects

Dombo PERSON · 8× FDA ORG · 4× Alloy Health ORG · 1× Fox News Digital ORG · 1× Kudzai Dombo PERSON · 1× Los Angeles GPE · 1× Menopause Society ORG · 1× U.S. GPE · 1× the Food and Drug Administration ORG · 1×

Narrative

When women ask their doctors about taking testosterone to help with menopause symptoms, they can run into insurance rejections, confusing workarounds and dosing guesswork, as no testosterone product is FDA-approved for women in the U.S. On Thursday, the Food and Drug Administration (FDA) convened a public workshop to examine the evidence, safety and research gaps surrounding testosterone therapy for menopausal women.
framing: assertive · carried by 1 article(s) · first seen 2026-09-19
🔮 Although women may hear about a wide range of potential benefits on social media and from friends, current evidence-based guidelines support testosterone therapy for only one indication: hypoactive sexual desire disorder (HSDD), or persistently low sexual desire.

Claims (23 extracted, 3 hedged)

When women ask their doctors about taking testosterone to help with menopause symptoms, they can run into insurance rejections, confusing workarounds and dosing guesswork, as no testosterone product is FDA-approved for women in the U.S. On Thursday, the Food and Drug Administration (FDA) convened a public workshop to examine the evidence, safety and research gaps surrounding testosterone therapy for menopausal women. asserted
Administration → ask → women
Interest in testosterone therapy has grown as more women seek treatment for symptoms such as low sexual desire, fatigue and reduced quality of life during menopause — yet the lack of an FDA-approved product has left physicians relying on off-label prescribing and compounded formulations. asserted
lack → grow → prescribing
Dr. Kudzai Dombo, a board-certified obstetrician-gynecologist, Menopause Society-certified practitioner, and prescribing physician at Alloy Health, said she sees this dynamic playing out daily in her own Los Angeles practice. asserted
dynamic → certify → practice
Once patients get settled on standard estrogen and progesterone regimens, "The immediate next question is, do I need testosterone?" Dombo told Fox News Digital. asserted
Dombo → settle → Digital
Although women may hear about a wide range of potential benefits on social media and from friends, current evidence-based guidelines support testosterone therapy for only one indication: hypoactive sexual desire disorder (HSDD), or persistently low sexual desire. uncertain
guidelines → hear → indication
Clinical evidence supporting its use for energy, mood, bone health or sleep remains limited — though many patients are eager to try it for those secondary benefits, according to Dombo. uncertain
patients → support → Dombo
Because no female-specific formulation exists, doctors must navigate off-label workarounds. asserted
doctors → exist → workarounds
They typically choose between using custom compounding pharmacies or micro-dosing FDA-approved male gel packets, which patients must carefully measure out at home. asserted
patients → choose → home
This lack of standardized options creates administrative and financial hurdles. asserted
lack → create → hurdles
Because the therapy is off-label, insurance routinely denies coverage, forcing clinicians and patients to improvise — a frustration that Dombo experienced firsthand. asserted
Dombo → deny → that
"When I was prescribed testosterone, my insurance denied coverage, and my physician recommended a compounded cream to avoid the administrative burden," Dombo recalled. asserted
Dombo → prescribe → burden
"I said, 'Well, I've already tried compounded and I actually want to try the gel.' asserted
I → say → gel
Using a discount coupon, she paid out of pocket and discovered that a 10-month supply of male gel packets was actually cheaper than a single month of compounded cream. asserted
supply → use → cream
"It's just an example, I think, of how we have to adapt to a system that has not supported patients when it comes to access to testosterone therapy," she said. asserted
she → think → therapy
Dosing male products can also present clinical challenges. asserted
Dosing → dose → challenges
Dombo described a patient in her private practice who precisely measured out one-tenth of a male gel packet daily using a syringe. asserted
who → describe → syringe
Despite three months of consistency, follow-up bloodwork showed no change in hormone levels, and the patient experienced no symptom relief. asserted
patient → follow → relief
"We're left to kind of decide, 'Well, what now?'" Dombo said. asserted
Dombo → leave → ?
We don't have a set guideline for how to be able to do this for women. asserted
We → have → women
We have to rely on the art of medicine." asserted
We → have → medicine
The latest federal meeting represents a critical step forward, according to Dombo, who believes grassroots advocacy from patients and clinicians is forcing regulatory action. uncertain
advocacy → represent → action
"We're not going to stop knocking on the door, because there are several of us who believe that women deserve to be able to have access to just what they need," she said. asserted
she → go → what
"Sexual health is part of your entire health," Dombo emphasized, expressing optimism that regulatory agencies will eventually adapt to support safer, standardized access. asserted
agencies → emphasize → access
💬Give feedback
🕘History 🎫Support